Late upper extremity embolic complications of occluded axillofemoral bypass graft (AxFG) or occluded axilloaxillary bypass graft (AxAG) are not frequently noted. A patient presented with acute right upper extremity thromboembolism 2 years after an AxFG occlusion. Computed tomography (CT) fi ndings revealed kinking and occlusion of the axillary artery at the anastomosis. Another patient presented with acute left upper extremity thromboembolism 2 years and 6 years after an AxAG occlusion. CT indicated a thrombus progressing from the occluded graft to the axillary artery. Surgical repair of the axillary artery was performed in both patients without any complications.
Introduction
The use of the axillofemoral bypass graft (AxFG) for treating high-risk patients with aortoiliac occlusive disease or infected prosthesis is well established. The complications of AxFG include acute thrombosis of the axillary artery, brachial plexus injury, and thromboembolism. However, late upper extremity thromboembolism in patients with occluded AxFG is rare, and this complication has been previously reported as axillofemoral bypass graft stump syndrome (AxFSS). 1) On the other hand, the use of the axilloaxillary artery bypass graft (AxAG) for symptomatic subclavian steal syndrome and/or arm ischemia also has been associated with late thromboembolism after AxAG occlusion. 2) Here, we report two cases that both involved the abovementioned complications.
Case 1
In December 2011, a 65-year-old man was admitted to our hospital due to a sudden onset of pain in the right arm. In 2003, a right axillary-bifemoral bypass was performed with an 8 mm externally supported polytetrafl uoroethylene (ePTFE) graft due to the occlusion of the right common iliac artery and stenosis of the left common iliac artery. In 2009, acute thromboembolism of the left femoral artery with AxFG occlusion was noted. Therefore, thrombectomy was performed and anticoagulation therapy with warfarin was initiated. Moreover, he underwent treatment of left common iliac artery stenosis by using a stent.
Upon examination, we did not detect any right brachial artery pulse, whereas ultrasonography showed a thrombus in the brachial artery. Thrombectomy was performed via the brachial artery and a small thrombus was removed. However, a decreased radial artery pulse was still detected. For further examination, a computed tomography (CT) scan was performed, which indicated "Y" elongation ( Fig. 1A) and occlusion of the right axillary artery at the anastomosis site. Therefore, we resected the graft, and reconstructed the axillary artery with end-to-end anastomosis (Fig. 1B) . At 20 months after the surgery, the patient was symptom-free with no recurrent embolization.
Surgical Repair of Axillary Graft Stump Syndrome thrombotic material that maybe released into the axillary circulation is one of the postulated mechanisms. 5) Furthermore, others have suggested that the lumen narrowing with irregurality of the wall either occurring as part of an intimal hyperplastic response or a confi guration of graft-axillary artery anastomosis and its formation into a "Y" confi guration as a result of undue tension contributes to distal embolization after graft thrombosis. [6] [7] [8] In the present cases, thrombotic material from the occluded graft was observed in case 2 and a "Y" confi guration of the anastomosis which led to the occlusion of axillary artery and thromboembolism of brachial artery was observed in case 1. We think it important to adjust the graft to the proper length to prevent undue tension at the initial surgery.
Case 2
A 63-year-old man was admitted to our hospital due to a sudden onset of pain in the left arm in September 2012. In 2003, AxAG surgery was performed with a 7 mm ePTFE graft due to stenosis of the left subclavian artery. However, in 2006, AxAG occlusion developed, but no treatment was initiated as the patient was asymptomatic. In 2008, acute thromboembolism of the left brachial artery developed, and thrombectomy and stent implantation at the left subclavian artery were performed. In June 2012, acute thromboembolism of the left brachial artery was noted, for which thrombectomy was performed and anticoagulation with warfarin was initiated.
Upon examination, no left brachial artery pulse was detected. Angiography showed a patent stent in the left subclavian artery and left brachial artery occlusion. During the postoperative course, following the thrombectomy, CT indicated the presence of a thrombus progressing from the occluded graft in the axillary artery (Fig. 2) , which was not detected by the angiography. Therefore, we detached the graft, removed the thrombus, and repaired the axillary artery with a saphenous vein patch. At 11 months after the surgery, he was symptom-free with no recurrent embolization.
Discussion
To our knowledge, 23 cases of AxFSS 3,4) and 1 case of late upper extremity thromboembolism after occlusion of AxAG 2) have been reported.
The mechanisms of AxFSS are believed to be multiple. The formation of a blind pouch containing soft Previous reports have suggested that anticoagulation therapy, 5) endovascular management, 1, 4) and surgical repair 3, 9) should be used to treat AxFSS. However, some reports have shown that anticoagulation could not prevent the recurrence of embolization. 3, 5) In the present cases, anticoagulation therapy with warfarin did not prevent the occurrence of thromboembolism. Moreover, endovascular management is not always an option and its long-term results remain unclear. In case 1, endovascular management would have been diffi cult because of artery kinking.
We believe that the treatment for an occluded axillary graft stump is not always necessary because late thorombosis occurs infrequently. However, once it occurs, we recommend surgical repair by detaching the occluded graft and reconstructing the axillary artery, due to the associated risk of repeated embolism.
Conclusions
Surgical treatment for an axillary graft stump should be considered in patients presenting late upper extremity thromboembolism after occlusion of an AxFG or AxAG.
Disclosure Statement
Hitoshi Kanamitsu and other co-authors have no confl icts of interest.
